Janus Henderson Group PLC Denali Therapeutics Inc. Transaction History

Janus Henderson Group PLC

$182 Billion
Q2 2024

A detailed history of Janus Henderson Group PLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 52,128 shares of DNLI stock, worth $1.56 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

52,128

Previous 52,718 1.12%

Holding current value

$1.56 Million

Previous $1.08 Million 11.93%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$14.96 - $23.22 $8,826 - $13,699	-590 Reduced 1.12%	52,128 $1.21 Million
Q1 2024 May 15, 2024	BUY	$15.83 - $23.35 $411 - $607	26 Added 0.05%	52,718 $1.08 Million
Q4 2023 Feb 14, 2024	SELL	$16.2 - $23.18 $1,215 - $1,738	-75 Reduced 0.14%	52,692 $1.13 Million
Q3 2023 Nov 14, 2023	BUY	$20.63 - $30.17 $268 - $392	13 Added 0.02%	52,767 $1.09 Million
Q2 2023 Aug 14, 2023	BUY	$23.37 - $32.96 $247,394 - $348,914	10,586 Added 25.1%	52,754 $1.56 Million
Q1 2023 May 15, 2023	BUY	$21.91 - $32.67 $575,772 - $858,534	26,279 Added 165.39%	42,168 $971,000
Q4 2022 Feb 14, 2023	SELL	$26.28 - $33.92 $26 - $33	-1 Reduced 0.01%	15,889 $441,000
Q3 2022 Nov 14, 2022	SELL	$25.97 - $38.53 $4,622 - $6,858	-178 Reduced 1.11%	15,890 $488,000
Q2 2022 Aug 15, 2022	SELL	$20.88 - $35.19 $1.41 Million - $2.38 Million	-67,627 Reduced 80.8%	16,068 $472,000
Q1 2022 May 16, 2022	SELL	$29.0 - $47.27 $486,272 - $792,623	-16,768 Reduced 16.69%	83,695 $2.69 Million
Q4 2021 Feb 14, 2022	BUY	$42.59 - $55.02 $3.94 Million - $5.09 Million	92,593 Added 1176.53%	100,463 $4.48 Million
Q3 2021 Nov 16, 2021	SELL	$48.48 - $78.23 $981,962 - $1.58 Million	-20,255 Reduced 72.02%	7,870 $397,000
Q4 2017 Feb 09, 2018	BUY	$15.04 - $21.45 $423,000 - $603,281	28,125	28,125 $440,000

Others Institutions Holding DNLI

# of Institutions

229

Shares Held

114M

Call Options Held

67.2K

Put Options Held

63.3K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $4.01B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Denali Therapeutics Inc. Transaction History